Supplemental Tables.docx (68.05 kB)
Download file

Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use - Supplemental Tables.docx

Download (68.05 kB)
dataset
posted on 06.05.2022, 09:13 by David Kaplan, Elaine Husni, Eunice Chang, Michael S. Broder, Caleb Paydar, Kata Bognar, Jessie Yan, Sven Richter, Pooja Desai, Ibrahim Khilfeh

  

Supplementary Table 1: Patient demographic characteristics and prescriber specialty


  

Supplementary Table 2: Baseline comorbidities


  

Supplementary Table 3: Baseline medication use


  

Supplementary Table 4: Baseline healthcare utilization, and costs


  

Supplementary Table 5: Number of index medication fills before biologic initiation during the 1-year follow-up period


  

Supplementary Table 6: First biologic medication used during the 1-year follow-up period among apremilast patients who initiated biologic


  

Supplementary Table 7: First biologic medication used during the 1-year follow-up period among methotrexate patients who initiated biologic


  

Supplementary Table 8: Biologic initiation adjusted results

Funding

Amgen, Inc. , (Grant / Award Number:)

History